PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsBrimonidine tartrate
Brimonidine tartrate
Download report
Favorite
Novartis Pharmaceuticals
Top OTC Drugs
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
194 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ocular hypertensionD009798EFO_1001069H40.0262121959
GlaucomaD005901EFO_0000516H40227241045
Open-angle glaucomaD005902EFO_0004190H40.1—61318441
RosaceaD012393—L71——44311
Intraocular pressureD007429——2——158
Low tension glaucomaD057066EFO_1001022H40.12———3—3
Ocular physiological phenomenaD009799—————123
Angle-closure glaucomaD015812—————112
Capsule opacificationD058442—H26.4———1—1
Relapsing-remitting multiple sclerosisD020529EFO_0003929————1—1
Show 8 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PresbyopiaD011305—H52.4636——15
Eye diseasesD005128EFO_0003966H44224—19
MiosisD015877HP_0000616H57.03—14——5
Allergic conjunctivitisD003233EFO_0007141H10.44—12—14
Refractive errorsD012030EFO_0003908H52.7121——4
ErythemaD004890HP_0010783L53.9——2—13
Diabetic retinopathyD003930EFO_0003770——31——3
Dry eye syndromesD015352—H04.12121——3
HyperemiaD006940EFO_0003822H34.821—2——3
Exfoliation syndromeD017889EFO_0004235———1—12
Show 4 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular degenerationD008268EFO_0001365H35.30—4———4
Healthy volunteers/patients————1——12
Macular edemaD008269———1———1
Hand-foot syndromeD060831EFO_1001893——1———1
Meibomian gland dysfunctionD000080343—H02.8811———1
Geographic atrophyD057092———1———1
Retinitis pigmentosaD012174HP_0000580H35.5211———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PseudophakiaD019591——1————1
FlushingD005483—R23.21————1
Alcohol-related disordersD019973—F101————1
Sjogren-larsson syndromeD016111Orphanet_816E71.31————1
VitrectomyD014821——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CataractD002386HP_0000518H26.9————22
HemorrhageD006470MP_0001914R58————22
PterygiumD011625—H11.0————11
CoronavirusD017934——————11
Hemophilia aD006467EFO_0007267D66————11
Ventricular dysfunctionD018754——————11
Atrial heart septal defectsD006344Orphanet_1478Q21.1————11
Pericardial effusionD010490HP_0001698I31.39————11
Acute kidney injuryD058186HP_0001919N17————11
HydronephrosisD006869EFO_0005562N13.30————11
Show 4 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,134 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
680 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use